With the development of society, allergens such as pollen, animal hair, blankets, curtains and chemicals have brought more and more troubles to people, among which, the most common asthma and rhinitis are mostly caused by allergens such as mites. Academician Zhong Nanshan pointed out that prevention is more important than cure in treating allergy patients, and atopic immunotherapy is an important direction. So, what is atopic immunotherapy? Specific immunotherapy (also known as desensitization therapy) is the only clinical treatment method that targets the causes of allergic diseases (such as allergic rhinitis, allergic asthma, etc.) so far, with both preventive and therapeutic significance, long-lasting efficacy and few side effects. The main principle is that the main allergenic protein is used to make desensitizing preparations of different concentrations, which are repeatedly injected subcutaneously over a period of time in small to large doses and low to high concentrations, gradually adjusting the immune mechanism in the patient’s body and inducing the patient to tolerate the allergen without producing an allergic reaction. In 1998, the WHO stated in its guidance document on immunotherapy that standardized desensitization therapy is the only allopathic treatment that can be initiated from altering the natural course of allergic disease, and that starting desensitization therapy early in the course of the disease may alter its long-term course. Is desensitization treatment available if allergy is suspected? No. There is a standardized system of diagnosis and treatment for standardized desensitization vaccine therapy. In patients with clinical allergic rhinitis or asthma, a skin prick test is first performed to identify the allergen. If dust mite allergy is confirmed, then treatment with Androda (standardized dust mite allergen vaccine) can be administered. Desensitization treatment is divided into an initial treatment phase, which is a weekly injection, gradually increasing from a starting dose to a maintenance dose, which takes about 4-6 months, and a maintenance treatment, which is an injection every 6-8 weeks for a total period of about 3 years. The effect is usually seen in 3-4 months, with significant results seen in 6 months. The efficacy of desensitization therapy is evident at the completion of the initial treatment and becomes more pronounced with maintenance therapy. The initial efficacy of the treatment can be seen in the reduction of allergic symptoms, the reduction of the dosage of conventional allopathic drugs, and the reduction of the frequency of allergic attacks during the high allergy season; the long-term treatment can also make more than 85% of patients free from conventional allopathic drugs, reduce the development of allergic rhinitis into allergic asthma, and reduce the chance of allergy to other substances. International studies have shown that the efficacy of desensitization treatment can be maintained for up to 10 years after completing 3 years of treatment.